INTENSE PULSED LIGHT (IPL) – TREATMENT STRATEGY FOR MEIBOMIAN GLAND DYSFUNCTION

Meibomian gland dysfunction (MGD) is a primary cause of dry eye syndrome, as the meibomian glands produce lipids that maintain tear film integrity and reduce its evaporation. Blockage of these glands can result in symptoms associated with dry eye disease. Intense pulsed light (IPL) therapy is a nove...

Full description

Saved in:
Bibliographic Details
Main Authors: Monika Dimitrova, Irina Kuneva
Format: Article
Language:English
Published: Peytchinski Publishing 2025-01-01
Series:Journal of IMAB
Subjects:
Online Access:https://www.journal-imab-bg.org/issues-2025/issue1/2025vol31-issue1-5962-5966.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832577757649829888
author Monika Dimitrova
Irina Kuneva
author_facet Monika Dimitrova
Irina Kuneva
author_sort Monika Dimitrova
collection DOAJ
description Meibomian gland dysfunction (MGD) is a primary cause of dry eye syndrome, as the meibomian glands produce lipids that maintain tear film integrity and reduce its evaporation. Blockage of these glands can result in symptoms associated with dry eye disease. Intense pulsed light (IPL) therapy is a novel treatment option for dry eye syndrome caused by MGD. Purpose. The purpose of our study is to assess the safety and effectiveness of IPL for treating dry eye syndrome caused by MGD in various age groups, by analyzing the non-invasive tear breakup time (NITBUT) and Schirmer's test results both before and after two IPL treatments. Materials and methods: A total of 120 subjects, each with varying degrees of MGD, underwent IPL treatment in both eyes. Each patient received two procedures spaced two weeks apart. Tear breakup time (TBUT) and Schirmer's test were evaluated at baseline and two weeks following the final treatment. Results: The majority of tests demonstrated improvement in key clinical parameters, including tear breakup time, Schirmer's test, meibum quality, and the Standard Evaluation of Eye Dryness Questionnaire. IPL therapy shows therapeutic potential for treating MGD, enhancing tear film quality, and alleviating dry eye symptoms. Conclusion: IPL presents a promising area for development, offering the potential for improved outcomes in patients with MGD, and is currently the focus of ongoing research.
format Article
id doaj-art-98d589f043e4496498375f3aa431b169
institution Kabale University
issn 1312-773X
language English
publishDate 2025-01-01
publisher Peytchinski Publishing
record_format Article
series Journal of IMAB
spelling doaj-art-98d589f043e4496498375f3aa431b1692025-01-30T16:40:56ZengPeytchinski PublishingJournal of IMAB1312-773X2025-01-013115962596610.5272/jimab.2025311.5962INTENSE PULSED LIGHT (IPL) – TREATMENT STRATEGY FOR MEIBOMIAN GLAND DYSFUNCTIONMonika Dimitrova0https://orcid.org/0009-0003-2695-5737Irina Kuneva1https://orcid.org/0009-0009-0384-0981Department of Ophthalmology, Faculty of Medicine, Medical University of Sofia, Bulgaria.Zora Eye Hospital, Sofia, Bulgaria.Meibomian gland dysfunction (MGD) is a primary cause of dry eye syndrome, as the meibomian glands produce lipids that maintain tear film integrity and reduce its evaporation. Blockage of these glands can result in symptoms associated with dry eye disease. Intense pulsed light (IPL) therapy is a novel treatment option for dry eye syndrome caused by MGD. Purpose. The purpose of our study is to assess the safety and effectiveness of IPL for treating dry eye syndrome caused by MGD in various age groups, by analyzing the non-invasive tear breakup time (NITBUT) and Schirmer's test results both before and after two IPL treatments. Materials and methods: A total of 120 subjects, each with varying degrees of MGD, underwent IPL treatment in both eyes. Each patient received two procedures spaced two weeks apart. Tear breakup time (TBUT) and Schirmer's test were evaluated at baseline and two weeks following the final treatment. Results: The majority of tests demonstrated improvement in key clinical parameters, including tear breakup time, Schirmer's test, meibum quality, and the Standard Evaluation of Eye Dryness Questionnaire. IPL therapy shows therapeutic potential for treating MGD, enhancing tear film quality, and alleviating dry eye symptoms. Conclusion: IPL presents a promising area for development, offering the potential for improved outcomes in patients with MGD, and is currently the focus of ongoing research.https://www.journal-imab-bg.org/issues-2025/issue1/2025vol31-issue1-5962-5966.pdfdry eye syndromemeibomian gland dysfunctionnon-invasive tear film breakup timeschirmer’s testipl treatment
spellingShingle Monika Dimitrova
Irina Kuneva
INTENSE PULSED LIGHT (IPL) – TREATMENT STRATEGY FOR MEIBOMIAN GLAND DYSFUNCTION
Journal of IMAB
dry eye syndrome
meibomian gland dysfunction
non-invasive tear film breakup time
schirmer’s test
ipl treatment
title INTENSE PULSED LIGHT (IPL) – TREATMENT STRATEGY FOR MEIBOMIAN GLAND DYSFUNCTION
title_full INTENSE PULSED LIGHT (IPL) – TREATMENT STRATEGY FOR MEIBOMIAN GLAND DYSFUNCTION
title_fullStr INTENSE PULSED LIGHT (IPL) – TREATMENT STRATEGY FOR MEIBOMIAN GLAND DYSFUNCTION
title_full_unstemmed INTENSE PULSED LIGHT (IPL) – TREATMENT STRATEGY FOR MEIBOMIAN GLAND DYSFUNCTION
title_short INTENSE PULSED LIGHT (IPL) – TREATMENT STRATEGY FOR MEIBOMIAN GLAND DYSFUNCTION
title_sort intense pulsed light ipl treatment strategy for meibomian gland dysfunction
topic dry eye syndrome
meibomian gland dysfunction
non-invasive tear film breakup time
schirmer’s test
ipl treatment
url https://www.journal-imab-bg.org/issues-2025/issue1/2025vol31-issue1-5962-5966.pdf
work_keys_str_mv AT monikadimitrova intensepulsedlightipltreatmentstrategyformeibomianglanddysfunction
AT irinakuneva intensepulsedlightipltreatmentstrategyformeibomianglanddysfunction